AnaptysBio, Inc (ANAB) stock
ANABNasdaqPharmaceutical PreparationsFiscal year ends June 30
$49.24+2.63 (+5.64%)
Close on Oct 19, 2026Market cap $2.28BP/E –Yield –
AnaptysBio gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
No gross profit figures for AnaptysBio
AnaptysBio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?